HIV and the IRB - PowerPoint PPT Presentation

1 / 26
About This Presentation
Title:

HIV and the IRB

Description:

45 CFR 46 does not formally designate persons with HIV and ... Screen saver on all CASI terminals. Screen saver on all workstations. Secure data entry rooms ... – PowerPoint PPT presentation

Number of Views:26
Avg rating:3.0/5.0
Slides: 27
Provided by: UNA80
Category:
Tags: hiv | irb | screensaver

less

Transcript and Presenter's Notes

Title: HIV and the IRB


1
HIV and the IRB
  • Christopher S. Murrill, PhD, MPH
  • Director of Research
  • HIV Epidemiology Program
  • New York City Department of Health and Mental
    Hygiene
  • September 10, 2004

2
Special Populations
  • 45 CFR 46 does not formally designate persons
    with HIV and AIDS as a special population.
    HOWEVER,
  • Local, state and federal law build in special
    protections for persons with HIV and persons at
    risk for HIV.
  • Almost 90,000 persons have been diagnosed and are
    known to be living with HIV and AIDS in NYC. A
    cumulative total of 143,000 persons has been
    diagnosed with AIDS since the epidemic began in
    1981.

3
Why Do PLWHA Merit Special Consideration?
  • They are vulnerable to
  • StigmaMSM, IDU
  • Mental Health problemspre-existing morbidity or
    reaction to diagnosis of fatal disease
  • Risk factors are sensitive, private behaviors
  • Sex
  • Drugs
  • They are at risk for
  • Domestic violence or abandonment if risk behavior
    or serostatus disclosed (teens, women, MSM)
  • Discrimination re jobs, housing, insurance
  • Coercion re vaccine and treatment trial
    participation, undue enticement from incentives
  • Many are poor, already marginalized

4
IRBs should be vigilant that
  • Research protocols demonstrate knowledge of state
    law re confidentiality and nondisclosure of HIV
    serostatus and HIV-related information
  • Research protocols demonstrate understanding of
    why HIV serostatus and related risk behaviors are
    so sensitive and HIV at-risk populations so
    vulnerable
  • Researchers understand their reporting
    responsibilities to the NYC and NYS Departments
    of Health
  • Research protocols incorporate comprehensive
    training and supervision protocols

5
New York State Public Health LawArticle 27F
  • Article 27F, Section 2782 protects confidential
    HIV-related information and defines the limits of
    disclosurewho, when, what, and under what
    circumstances HIV information can be disclosed.
  • Section 2783 provides for civil penalties for
    violation of 2782 if willful disclosure of
    protected information is found.
  • Penalty is levied per case, not per eventso if
    somebody steals 500 surveys with individually
    identifiable information on them out of a
    researchers backpack and sells them to Act Up or
    the Daily News, the researcher is liable for 500
    disclosures
  • Make sure that the protocol demonstrates
    knowledge of the law and adequate data security
    measures

6
HIV Research and Human Subjects Protection
Special Considerations
  • Under NY State Public Health Law, HIV infection
    is a reportable disease.
  • HIV research involves the collection of highly
    sensitive information (HIV status, sexual
    behaviors, illicit drug using behaviors).
  • Strict rules apply to the disclosure of such
    information.
  • Maintaining the confidentiality of such
    information must be adhered to and is the
    responsibility of the entire research team.

7
HIV Surveillance vs. HIV Research
  • HIV is a reportable condition in NY State
  • AIDS has been reportable since 1983
  • HIV has been reportable since June 1, 2000
  • Distinction between public health practice
    (surveillance, outbreak investigation) and public
    health research can sometimes be difficulte.g.,
    a case control study that is part of an outbreak
    investigation, or a follow-up study to a risk
    factor group identified in surveillance
  • Behavioral risk data that are not required for
    surveillance fall into the category of research

8
Public Health Research is Public Health, but it
is still Research!
  • Public health research is an activity that is
    designed to answer an important question or test
    a hypothesis or intervention that may have broad
    public health significance.
  • It does not directly benefit the patient or
    participant. It may benefit others in the long
    run.

9
Who Must Comply with Public Health Research
Activities?
  • EVERYONE must comply with reporting,
    surveillance, and outbreak investigations
  • NO ONE is compelled to comply with any research
    activity.
  • All participation in research is voluntary.
  • Consent must be freely given by the participant
    after he or she is completely informed about the
    purpose, methods and activities involved in the
    study.
  • Patients must be given ample opportunity to weigh
    and discuss the risks and benefits of
    participation.

10
Examples of Low Risk HIV Research
  • Anonymous survey
  • Confidential survey
  • Chart review (common form of epi research)
  • Anonymous or confidential blood draw plus survey
  • Participation in a behavioral intervention trial
    (may not be low risk!)
  • Testing of blinded blood remaining from a
    diagnostic blood test (common form of
    epidemiologic research)

11
Examples of Greater than Minimal Risk HIV
Research
  • Randomized controlled trial of a multi-drug
    treatment regimen for primary HIV infection
  • Randomized placebo controlled trial of an
    experimental HIV vaccine
  • Randomized controlled trial of a genetically
    engineered CD4 blocker
  • Randomized controlled trial of PI vs. non-PI
    containing multi-drug regimen

12
Protection of Privacy and Confidentiality
  • The confidentiality of all persons whose
    individually identifiable health information is
    collected by routine reporting or public health
    research is protected by
  • Law
  • Ethics
  • Professional Standards

13
Confidentiality in Research General Principles
  • All research data are considered confidential
  • Research data are collected to benefit society or
    to provide non-surveillance-related public health
    information. The patient does not benefit
    personally from the research.
  • Part of our respect for the patient in this
    situation derives from his willingness to
    participate despite the lack of personal benefit.
  • An incentive is not a benefitit is a
    reimbursement for time and effort.

14
The Trust of the Research Participant General
Principles
  • Research participants trust that we collect these
    data for a legitimate public health or research
    purpose.
  • They are doing us a favor by agreeing to
    participate and allowing their medical and
    behavioral information to be entered into the
    study.
  • Research participants entrust us with maintaining
    the confidentiality of their data.
  • This is a sacred trust that can never be
    violated.

15
IRBs need to ensure that research protocols cover
these principles, and that field and interview
personnel are trained and supervised
  • The only relationship between the research staff
    and participant is a professional one.
  • Field staff cannot use survey activities to meet
    people socially.
  • When encountering participants in public, field
    staff must wait for them to acknowledge the staff
    person.
  • Field staff must refrain from showing any
    personal interest in a participant.
  • Field staff must learn to show empathy during
    study activities but maintain the professional
    relationship.

16
Recruitment Issues
  • Field staff must maintain the professional
    boundary between the participant and researcher
    by NOT recruiting friends and colleagues
  • When approaching someone or when sending out
    letters/placing phone calls field staff must not
    advertise the study as an HIV study. Use the
    term health survey instead.
  • Special considerations apply for more
    vulnerable population groups such as gay youth,
    illicit drug users, sex workers, etc.

17
Informed Consent Standard Principles ApplyMake
Sure They are Incorporated!
  • Informed consent must be obtained from the
    recruited participant prior to the administration
    of a survey, specimen collection, and/or HIV
    testing.
  • Consent is a process, not a rubber-stamp
    signature on a form.
  • Purpose, methods and activities of the study must
    be explained and the person must be provided the
    time to think carefully and ask questions before
    having to decide whether or not they want to
    participate.
  • New York State requires an additional consent for
    HIV testing.

18
(No Transcript)
19
Consent Forms Standard Principles Apply
  • Must include the following items at or below 8th
    grade reading level
  • Purpose of the study
  • Description of study procedures
  • Confidentiality
  • Risk and Benefits to the individual
  • Reimbursement of time
  • Participation and withdrawal is voluntary
  • Alternatives to being in the studyno penalty for
    not participating
  • Contact information of lead scientist and local
    IRB chair or designee.
  • Signature lines

20
Additional Considerations re Consent
  • Additional consent is required for the storage of
    HIV specimens for future testing purposes.
  • Individuals whose HIV results are associated with
    personal identifiers MUST be informed of their
    test results and provided appropriate counseling.
  • Subjects should be assured that any genetic
    testing is for HIV subtype and resistance and NOT
    for testing of their own genes

21
Waiver of Signed Informed Consent
  • Anonymous surveys may request a waiver on the
    requirement for written informed consent. Under
    Federal Regulations Title 46, Section 117,
    Documentation of Informed Consent, paragraph (c)
  • An IRB may waive the requirement for the
    investigator to obtain a signed informed consent
    for some or all subjects if it finds either
  • (1) That the only record linking the subject and
    the research would be the consent document and
    the principal risk would be the potential harm
    resulting from a breach of confidentiality. Each
    subject would be asked whether the subject wants
    documentation linking the subject with the
    research, and the subjects wishes will govern
    or
  • That the research presents no more than minimal
    risk of harm to subjects and involves no
    procedures for which written consent is normally
    required outside of the research context.
  • Only under very unusual circumstances should an
    IRB waive the need for written informed consent
    (e.g., anonymous street survey)

22
Teenagers and HIV
  • Teens may be sexually active without their
    parents knowledge
  • Gay and TG teens may not be out to their
    parents or guardians
  • Disclosure of their behavior or serostatus may
    put them at risk for violence or abandonment
  • Asking parent for consent for survey
    participation can become problematic
  • In New York State, teens can consent to an HIV
    test, an STD exam, and a pregnancy test--but this
    is consent for medical care, not research
  • Assess each research application on its own
    meritsbalance need for adequate protection for
    the teenage subject (including assessment of
    capacity to consent) and adequate respect to the
    rule of parental consent

23
Ethics of HIV ResearchNew Standards
  • HIV research should give something back to the
    consenting participant, I.e., dont just take the
    data or blood and run!
  • Build into the protocol adequate resources to get
    test results back to the participant
  • Build into the protocol adequate resources to
    provide active referrals to appropriate community
    based services (primary care, prevention, and
    partner notification referrals)
  • Be ready to provide crisis intervention if field
    staff identify a MH problem during an interview
    or after a test result is received
  • Reimburse subjects for the time they have given
    to the research project

24
Participant Follow-up
  • Maintaining contact with participant may be
    necessary for the provision of HIV test results
    and follow-up interviews (intervention trials or
    cohort studies).
  • Provide appointment cards with study name (no
    reference to HIV)
  • Use available contact information (phone number,
    mailing address) for reminder letters or calls

25
Protocols Must Incorporate Measures to Ensure
Data Security
  • Physical security of laptops, PDAs, and paper
    forms, that go into the fieldNO NAMES!
  • Screen saver on all CASI terminals
  • Screen saver on all workstations
  • Secure data entry rooms
  • Double passwords on databases
  • Separate names files survey and serostatus data
    identified ONLY by study ID
  • Specify how long identifiers will be retained and
    why, and approximate date when all links will be
    destroyed

26
Summary
  • ConfidentialityNew York State law officially
    designates HIV serostatus and related data as
    protected health information. Make sure this is
    clear in the protocol.
  • Data securityall protocols must incorporate
    adequate physical and electronic means to secure
    data researchers should use common sense about
    what can go wrong.
  • Protocol must show respect for the patients
    vulnerabilitystigmatized disease, stigmatized
    risk behaviors.
  • Training and ongoing supervision of staff are
    critical elements of any research protocol.
Write a Comment
User Comments (0)
About PowerShow.com